124 related articles for article (PubMed ID: 21827780)
1. Study of the effect of thiols on the vasodilatory potency of S-nitrosothiols by using a modified aortic ring assay.
Giustarini D; Tsikas D; Rossi R
Toxicol Appl Pharmacol; 2011 Oct; 256(2):95-102. PubMed ID: 21827780
[TBL] [Abstract][Full Text] [Related]
2. Extra-platelet low-molecular-mass thiols mediate the inhibitory action of S-nitrosoalbumin on human platelet aggregation via S-transnitrosylation of the platelet surface.
Tsikas D
Amino Acids; 2021 Apr; 53(4):563-573. PubMed ID: 33586042
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of S-nitrosothiols: the role of nitric oxide.
Mathews WR; Kerr SW
J Pharmacol Exp Ther; 1993 Dec; 267(3):1529-37. PubMed ID: 7903392
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
5. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
[TBL] [Abstract][Full Text] [Related]
6. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
Smith MP; Humphrey SJ; Kerr SW; Mathews WR
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of thiol-mediated decomposition of S-nitrosothiols.
Hu TM; Chou TC
AAPS J; 2006 Jul; 8(3):E485-92. PubMed ID: 17025266
[TBL] [Abstract][Full Text] [Related]
8. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic uses for S-nitrosothiols.
Richardson G; Benjamin N
Clin Sci (Lond); 2002 Jan; 102(1):99-105. PubMed ID: 11749666
[TBL] [Abstract][Full Text] [Related]
10. Vasorelaxation induced by the essential oil of Croton nepetaefolius and its constituents in rat aorta are partially mediated by the endothelium.
Magalhães PJ; Lahlou S; Jucá DM; Coelho-de-Souza LN; da Frota PT; da Costa AM; Leal-Cardoso JH
Fundam Clin Pharmacol; 2008 Apr; 22(2):169-77. PubMed ID: 18353112
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
[TBL] [Abstract][Full Text] [Related]
12. S,S'-dinitrosobucillamine, a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols.
Dahboul F; Perrin-Sarrado C; Boudier A; Lartaud I; Schneider R; Leroy P
Eur J Pharmacol; 2014 May; 730():171-9. PubMed ID: 24625595
[TBL] [Abstract][Full Text] [Related]
13. Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats.
Lewis SJ; Bhopatkar MY; Walton TM; Bates JN
Eur J Pharmacol; 2005 Dec; 528(1-3):144-9. PubMed ID: 16321377
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
15. S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide.
Liu Z; Rudd MA; Freedman JE; Loscalzo J
J Pharmacol Exp Ther; 1998 Feb; 284(2):526-34. PubMed ID: 9454793
[TBL] [Abstract][Full Text] [Related]
16. Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols.
Liu T; Schroeder HJ; Wilson SM; Terry MH; Romero M; Longo LD; Power GG; Blood AB
Free Radic Biol Med; 2016 Feb; 91():215-23. PubMed ID: 26686469
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator actions of the endothelium-derived relaxing factor L-S-nitrosocysteine in anaesthetized rats are markedly diminished by peroxynitrite.
Graves JE; Bates JN; Kooy NW; Lewis SJ
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1137-41. PubMed ID: 16445582
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between the observed stability and pharmacological properties of S-nitroso derivatives of glutathione and cysteine-related peptides.
Tullett JM; Rees DD; Shuker DE; Gescher A
Biochem Pharmacol; 2001 Nov; 62(9):1239-47. PubMed ID: 11705457
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin.
Kaufmann MA; Castelli I; Pargger H; Drop LJ
J Pharmacol Exp Ther; 1995 May; 273(2):855-62. PubMed ID: 7752090
[TBL] [Abstract][Full Text] [Related]
20. Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent.
Khurana S; Yamada M; Wess J; Kennedy RH; Raufman JP
Eur J Pharmacol; 2005 Jul; 517(1-2):103-10. PubMed ID: 15964566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
